Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion type Assertion NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_head.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion description "[Anti-FLT3 antibodies may also prove to be an excellent way of targeting FLT3 in AML and acute lymphocytic leukemia (ALL) by inhibiting signaling and through antibody-dependent cell-mediated cytotoxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_provenance.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion evidence source_evidence_literature NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_provenance.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion SIO_000772 18760705 NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_provenance.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion wasDerivedFrom befree-2016 NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_provenance.
- NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_assertion wasGeneratedBy ECO_0000203 NP690850.RAeMpr4ANJBD8EEb2nhuvH_5xKsSCtkB2beF-WdaIpxjk130_provenance.